Medicare May Require Part D Plans To Provide Point-of-Sale Rebates
CMS outlines possible approach to point-of-sale rebates in Medicare Part D, recognizing that using rebates to lower cost sharing for 'many' would increase premiums for all.
You may also be interested in...
Part D Rebates: Policy Tweak Would Retain Manufacturer ‘Contributions’
Peter Bach’s new approach to calculating TrOOP cost in Medicare would prevent big savings to manufacturers from point-of-sale rebates.
Medicare Part D Rule Offers Modest Drug Price Savings, No Point-of-Sale Rebates
CMS Administrator Verma declined to suggest a timeframe for when such a policy redirecting negotiated drug rebates to offset cost sharing in Medicare Part D might be implemented.
Impact Of Rebates On Drug Pricing Will Diminish -- CMS Experts
Actuaries with the US Centers for Medicare and Medicaid Services predict the share of retail prescription drug costs represented by manufacturer rebates will level off in the coming years, resulting in higher drug pricing trends across government and commercial insurance.